Current Schizophrenia Prevalence and Incidence in the USA

Prevalence Data

• The American Psychiatric Association's 2020 practice guideline cites a lifetime prevalence of approximately 0.7%, which represents the most recent authoritative estimate 1

Factors Affecting Prevalence Estimates

• Prevalence estimates vary based on several methodological factors, including study location and population demographics, case-finding approaches, and methods used for diagnostic confirmation 1, 2, 3

Mortality and Morbidity

• Schizophrenia is associated with significantly increased mortality, with standardized mortality ratios 2-4 times higher than the general population 1
• About 4-10% of persons with schizophrenia die by suicide, with rates highest among males early in the course of the disorder 1
• Schizophrenia is ranked among the top 20 causes of disability worldwide 1

Incidence Rate

• Schizophrenia incidence peaks have been observed in women aged 20-29 and 30-39 years 4

Special Populations

• Women with schizophrenia represent a particularly vulnerable population during pregnancy and childbirth, with higher risks of various complications for both mothers and infants 3, 4

Epidemiology of Schizophrenia

Global Burden

• Schizophrenia affects approximately 0.7% of the global population during their lifetime, with 0.32% of the population affected at any given time, representing a significant worldwide health burden with substantial mortality and morbidity implications 5

Special Populations

• Women with schizophrenia represent a particularly vulnerable population during pregnancy and childbirth 6
• Pregnancies in women with schizophrenia are associated with significantly increased risks of gestational diabetes, pre-eclampsia/eclampsia, antepartum hemorrhage, preterm and very preterm delivery, stillbirths, and infant mortality 6
• These findings highlight the need for specialized perinatal care for this population 6